Skip to Main Content

Paper Details

<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma.
Cancer Discov
34
2022
MYC, PDAC, TAMs, cancer, downstream targets, human, mouse, multi-fluorescent lineage-labeled, pancreatic adenocarcinoma, pancreatic ductal adenocarcinoma, patients, primary tumors, tumor, tumor associated macrophages
Author NameAffiliation
Komal S RathiDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Komal S RathiDepartment of Biomedical and Health informatics and Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Komal S RathiDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Komal S RathiDepartment of Biomedical and Health informatics and Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Pichai RamanDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Pichai RamanDepartment of Biomedical and Health informatics and Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Pichai RamanDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Pichai RamanDepartment of Biomedical and Health informatics and Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Ian W FolkertPenn Pancreatic Cancer Research Center and Abramson Family Cancer Research Institute, University of Pennsylvania
Ian W FolkertHospital of the University of Pennsylvania
Faiyaz NottaOntario Institute for Cancer Research
Faiyaz NottaPrincess Margaret Cancer Centre
Faiyaz NottaUniversity of Toronto
  • 1 - 13

Datasets